November is National COPD Awareness Month. This month is meant to bring attention to the disease as it's one of the leading ...
The pulmonary emphysema market is poised for steady growth driven by rising COPD prevalence, an aging global population, and greater diagnostic awareness. Advances in inhaled therapies, targeted ...
Pulmonary Hypertension (PH) is a hidden killer in Nigeria. Frequently mistaken for asthma or other cardiac and respiratory diseases, PH is a progressive, life-threatening condition that causes the ...
1 Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China 2 North Sichuan Medical College, Nanchong, Sichuan, China ...
Background Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of cardiovascular disease (CVD). The extent to which the excess CVD risk is captured by risk factors in ...
Dear Dr. Roach: I have hereditary hemochromatosis (HH) and atrial fibrillation. My AFib burden seems to vary with my iron levels. My AFib went from 58% to less than 2% in two weeks after I had a ...
BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback